Literature DB >> 6145970

Inhibition of drug metabolism by omeprazole.

D A Henry, J F Gerkens, P Brent, K Somerville.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6145970     DOI： 10.1016/s0140-6736(84)92039-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

Review 1.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

Review 2.  Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.

Authors:  S P Clissold; D M Campoli-Richards
Journal:  Drugs       Date:  1986-07       Impact factor: 9.546

Review 3.  Clinical implications of drug interactions with the cytochrome P-450 enzyme system associated with omeprazole.

Authors:  T J Humphries
Journal:  Dig Dis Sci       Date:  1991-12       Impact factor: 3.199
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.